Page 2 - Embecta News Today

Embecta (NASDAQ:EMBC – Get Free Report) and Teleflex (NYSE:TFX – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, analyst recommendations, dividends, earnings and profitability. Earnings & Valuation This table compares Embecta and Teleflex’s top-line […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 3,330,000 shares, an increase of 6.7% from the October 31st total of 3,120,000 shares. Currently, 5.9% of the shares of the company are short […]

Embecta (NASDAQ:EMBC – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $1.90-2.10 for the period, compared to the consensus EPS estimate of $1.94. The company issued revenue guidance of $1.085-1.105 billion, compared to the consensus revenue estimate of $1.11 billion. Embecta Stock Performance […]

Embecta (NASDAQ:EMBC – Get Free Report) posted its earnings results on Tuesday. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.19, MarketWatch Earnings reports. Embecta had a net margin of 6.28% and a negative return on equity of 20.56%. The firm had revenue of $281.90 million during the […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totalling 4,000,000 shares, a drop of 20.2% from the September 30th total of 5,010,000 shares. Based on an average trading volume of 623,900 shares, the short-interest ratio is […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 5,010,000 shares, a growth of 8.7% from the September 15th total of 4,610,000 shares. Based on an average daily trading volume, of 620,700 shares, the short-interest ratio […]

Cacti Asset Management LLC lessened its holdings in Embecta Corp. (NASDAQ:EMBC – Free Report) by 7.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 61,088 shares of the company’s stock after selling 4,723 shares during the period. Cacti Asset Management LLC owned approximately […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) Director David F. Melcher bought 6,233 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The shares were acquired at an average cost of $15.77 per share, with a total value of $98,294.41. Following the transaction, the director now owns 27,698 shares in […]

Principal Financial Group Inc. lessened its position in Embecta Corp. (NASDAQ:EMBC – Free Report) by 3.3% during the first quarter, Holdings Channel reports. The institutional investor owned 353,613 shares of the company’s stock after selling 12,076 shares during the quarter. Principal Financial Group Inc.’s holdings in Embecta were worth $9,944,000 as of its most recent […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) shares gapped down prior to trading on Thursday after Morgan Stanley lowered their price target on the stock from $19.00 to $16.00. The stock had previously closed at $17.65, but opened at $17.28. Morgan Stanley currently has an underweight rating on the stock. Embecta shares last traded at […]